Sign in

CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
811591163
Phone
617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 4 Shares withheld for taxes Chief Medical Officer gave up 1,917 shares (to pay taxes)
  4. 424B5 Offering Prospectus
  5. 10-Q Report Quarterly Report
  6. 4 Option exercise 10% owner acquired 500 shares (option exercise)
  7. S-3ASR Offering Registration Statement
  8. 4 Option exercise 10% owner acquired 1,500 shares (option exercise)
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 10-Q Report Quarterly Report
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. SCHEDULE 13D/A Stake Beneficial Ownership Report
  17. 4 Open-market sale 10% owner sold 213 shares at $19.75 ($4,207)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 8-K Event Executive or director change

Page 1 of 24 · 464 filings